Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolution

A high‐resolution structure of a ligand‐bound, soluble form of human monoglyceride lipase (MGL) is presented. The structure highlights a novel conformation of the regulatory lid‐domain present in the lipase family as well as the binding mode of a pharmaceutically relevant reversible inhibitor. Analysis of the structure lacking the inhibitor indicates that the closed conformation can accommodate the native substrate 2‐arachidonoyl glycerol. A model is proposed in which MGL undergoes conformational and electrostatic changes during the catalytic cycle ultimately resulting in its dissociation from the membrane upon completion of the cycle. In addition, the study outlines a successful approach to transform membrane associated proteins, which tend to aggregate upon purification, into a monomeric and soluble form.

[1]  M. Mathieu,et al.  Structural basis for human monoglyceride lipase inhibition. , 2010, Journal of molecular biology.

[2]  J. Ferrer,et al.  Crystal Structure of the Human Monoacylglycerol Lipase, a Key Actor in Endocannabinoid Signaling , 2010, Chembiochem : a European journal of chemical biology.

[3]  B. Cravatt,et al.  A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol , 2007, Chemistry & biology.

[4]  Randy J. Read,et al.  Dauter Iterative model building , structure refinement and density modification with the PHENIX AutoBuild wizard , 2007 .

[5]  J. Wouters,et al.  Disulfiram is an Inhibitor of Human Purified Monoacylglycerol Lipase, the Enzyme Regulating 2‐Arachidonoylglycerol Signaling , 2007, Chembiochem : a European journal of chemical biology.

[6]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[7]  Gerhard Klebe,et al.  PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations , 2007, Nucleic Acids Res..

[8]  T. Vanderah,et al.  CB2 cannabinoid receptor mediation of antinociception. , 2006, Pain.

[9]  F. Leblond,et al.  Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: A new model of neuropathic pain , 2005, Neuroscience.

[10]  E. Ponomarev,et al.  Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli , 2005, Journal of neurochemistry.

[11]  Daumantas Matulis,et al.  Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. , 2005, Biochemistry.

[12]  T. Kaneko,et al.  Crystal structures of RsbQ, a stress‐response regulator in Bacillus subtilis , 2005, Protein science : a publication of the Protein Society.

[13]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[14]  D. Piomelli,et al.  RNA Interference Suggests a Primary Role for Monoacylglycerol Lipase in the Degradation of the Endocannabinoid 2-Arachidonoylglycerol , 2004, Molecular Pharmacology.

[15]  A. Hohmann,et al.  Selective Activation of Cannabinoid CB2 Receptors Suppresses Hyperalgesia Evoked by Intradermal Capsaicin , 2004, Journal of Pharmacology and Experimental Therapeutics.

[16]  T. Vanderah,et al.  Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2 Cannabinoid Receptors , 2003, Anesthesiology.

[17]  T. Vanderah,et al.  Inhibition of pain responses by activation of CB(2) cannabinoid receptors. , 2002, Chemistry and physics of lipids.

[18]  T. Freund,et al.  A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. , 2002, Chemistry and physics of lipids.

[19]  A. Hohmann.  Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives. , 2002, Chemistry and physics of lipids.

[20]  K. Longenecker,et al.  The impact of Glu-->Ala and Glu-->Asp mutations on the crystallization properties of RhoGDI: the structure of RhoGDI at 1.3 A resolution. , 2002, Acta crystallographica. Section D, Biological crystallography.

[21]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination , 2022 .

[22]  T. Freund,et al.  Brain monoglyceride lipase participating in endocannabinoid inactivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Vanderah,et al.  CB2 cannabinoid receptor-mediated peripheral antinociception , 2001, Pain.

[24]  Nathan A. Baker,et al.  Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  K. Longenecker,et al.  Protein crystallization by rational mutagenesis of surface residues: Lys to Ala mutations promote crystallization of RhoGDI. , 2001, Acta crystallographica. Section D, Biological crystallography.

[26]  Christopher J. Lee,et al.  The GeneMine system for genome/proteome annotation and collaborative data mining , 2001, IBM Syst. J..

[27]  M. Holmquist,et al.  Alpha/Beta-hydrolase fold enzymes: structures, functions and mechanisms. , 2000, Current protein & peptide science.

[28]  S. McMahon,et al.  Cannabinoid CB1 Receptor Expression in Rat Spinal Cord , 2000, Molecular and Cellular Neuroscience.

[29]  S. Narula,et al.  Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. , 2000, Molecular pharmacology.

[30]  H. Tornqvist,et al.  Expression, purification, and characterization of histidine-tagged mouse monoglyceride lipase from baculovirus-infected insect cells. , 2000, Protein expression and purification.

[31]  K. Waku,et al.  Evidence That 2-Arachidonoylglycerol but Not N-Palmitoylethanolamine or Anandamide Is the Physiological Ligand for the Cannabinoid CB2 Receptor , 2000, The Journal of Biological Chemistry.

[32]  R. Mechoulam,et al.  HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Pflugrath,et al.  The finer things in X-ray diffraction data collection. , 1999, Acta crystallographica. Section D, Biological crystallography.

[34]  A. Goldman,et al.  Of barn owls and bankers: a lush variety of α/β hydrolases , 1999 .

[35]  A. Goldman,et al.  Of barn owls and bankers: a lush variety of alpha/beta hydrolases. , 1999, Structure.

[36]  M. Herkenham,et al.  Cannabinoid receptors undergo axonal flow in sensory nerves , 1999, Neuroscience.

[37]  J L Sussman,et al.  Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules. , 1998, Acta crystallographica. Section D, Biological crystallography.

[38]  U. Hellman,et al.  cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase , 1997, The Journal of Biological Chemistry.

[39]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[40]  O. Nobili,et al.  Purification and properties of a monoacylglycerol lipase in human erythrocytes. , 1995, The Biochemical journal.

[41]  S. Galiègue,et al.  Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. , 1995, European journal of biochemistry.

[42]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[43]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[44]  M. Levitt.  Accurate modeling of protein conformation by automatic segment matching. , 1992, Journal of molecular biology.

[45]  Joel L. Sussman,et al.  The α/β hydrolase fold , 1992 .

[46]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[47]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[48]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[49]  P. Belfrage,et al.  Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. , 1976, The Journal of biological chemistry.

[50]  P. Vekilov,et al.  Entropy and surface engineering in protein crystallization. , 2006, Acta crystallographica. Section D, Biological crystallography.

[51]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[52]  Joseph D. Kwasnoski,et al.  High-density miniaturized thermal shift assays as a general strategy for drug discovery. , 2001, Journal of biomolecular screening.

[53]  S. McMahon,et al.  Cannabinoid CB(1) receptor expression in rat spinal cord. , 2000, Molecular and cellular neurosciences.

[54]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[55]  S J Remington,et al.  The alpha/beta hydrolase fold. , 1992, Protein engineering.